IRIS Accounts Production v24.3.2.46 08597448 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh085974482023-07-31085974482024-07-31085974482023-08-012024-07-31085974482022-07-31085974482022-08-012023-07-31085974482023-07-3108597448ns15:EnglandWales2023-08-012024-07-3108597448ns14:PoundSterling2023-08-012024-07-3108597448ns10:Director12023-08-012024-07-3108597448ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3108597448ns10:SmallEntities2023-08-012024-07-3108597448ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3108597448ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3108597448ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3108597448ns10:FullAccounts2023-08-012024-07-310859744812023-08-012024-07-3108597448ns10:Director22023-08-012024-07-3108597448ns10:Director32023-08-012024-07-3108597448ns10:RegisteredOffice2023-08-012024-07-3108597448ns5:CurrentFinancialInstruments2024-07-3108597448ns5:CurrentFinancialInstruments2023-07-3108597448ns5:ShareCapital2024-07-3108597448ns5:ShareCapital2023-07-3108597448ns5:RetainedEarningsAccumulatedLosses2024-07-3108597448ns5:RetainedEarningsAccumulatedLosses2023-07-3108597448ns5:NetGoodwill2023-08-012024-07-3108597448ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108597448ns5:PlantMachinery2023-08-012024-07-3108597448ns5:NetGoodwill2023-07-3108597448ns5:NetGoodwill2024-07-3108597448ns5:NetGoodwill2023-07-3108597448ns5:LandBuildings2023-07-3108597448ns5:PlantMachinery2023-07-3108597448ns5:LandBuildings2023-08-012024-07-3108597448ns5:LandBuildings2024-07-3108597448ns5:PlantMachinery2024-07-3108597448ns5:LandBuildings2023-07-3108597448ns5:PlantMachinery2023-07-3108597448ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3108597448ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-31
REGISTERED NUMBER: 08597448 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 July 2024

for

CENTRELINE AVIATION MEDICAL SERVICES LTD

CENTRELINE AVIATION MEDICAL SERVICES LTD (REGISTERED NUMBER: 08597448)

Contents of the Financial Statements
for the Year Ended 31 July 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CENTRELINE AVIATION MEDICAL SERVICES LTD

Company Information
for the Year Ended 31 July 2024







DIRECTORS: Ghuman Investments Ltd
Dr C King
Dr M F Cooper





REGISTERED OFFICE: 35 Massetts Road
Horley
Surrey
RH6 7DQ





REGISTERED NUMBER: 08597448 (England and Wales)





ACCOUNTANTS: Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

CENTRELINE AVIATION MEDICAL SERVICES LTD (REGISTERED NUMBER: 08597448)

Balance Sheet
31 July 2024

2024 2023
Notes £ £
FIXED ASSETS
Intangible assets 4 - 8,000
Property, plant and equipment 5 841,042 802,876
841,042 810,876

CURRENT ASSETS
Debtors 6 202,700 156,250
Cash at bank and in hand 394,353 190,874
597,053 347,124
CREDITORS
Amounts falling due within one year 7 (247,909 ) (199,425 )
NET CURRENT ASSETS 349,144 147,699
TOTAL ASSETS LESS CURRENT LIABILITIES 1,190,186 958,575

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,190,086 958,475
SHAREHOLDERS' FUNDS 1,190,186 958,575

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CENTRELINE AVIATION MEDICAL SERVICES LTD (REGISTERED NUMBER: 08597448)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 January 2025 and were signed on its behalf by:





Ghuman Investments Ltd - Director


CENTRELINE AVIATION MEDICAL SERVICES LTD (REGISTERED NUMBER: 08597448)

Notes to the Financial Statements
for the Year Ended 31 July 2024


1. STATUTORY INFORMATION

Centreline Aviation Medical Services LTD is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2014, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


CENTRELINE AVIATION MEDICAL SERVICES LTD (REGISTERED NUMBER: 08597448)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2023 - 9 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£
COST
At 1 August 2023
and 31 July 2024 80,000
AMORTISATION
At 1 August 2023 72,000
Charge for year 8,000
At 31 July 2024 80,000
NET BOOK VALUE
At 31 July 2024 -
At 31 July 2023 8,000

CENTRELINE AVIATION MEDICAL SERVICES LTD (REGISTERED NUMBER: 08597448)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


5. PROPERTY, PLANT AND EQUIPMENT
Plant and
Land and machinery
buildings etc Totals
£ £ £
COST
At 1 August 2023 779,535 119,831 899,366
Additions - 50,141 50,141
At 31 July 2024 779,535 169,972 949,507
DEPRECIATION
At 1 August 2023 - 96,490 96,490
Charge for year - 11,975 11,975
At 31 July 2024 - 108,465 108,465
NET BOOK VALUE
At 31 July 2024 779,535 61,507 841,042
At 31 July 2023 779,535 23,341 802,876

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade debtors 202,700 156,250

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Bank loans and overdrafts 4,465 7,576
Trade creditors 40,293 39,255
Taxation and social security 199,651 149,015
Other creditors 3,500 3,579
247,909 199,425

8. RELATED PARTY DISCLOSURES

During the year, total dividends of £196,000 were paid to the directors .